Vaccines
|
223
6. Vaccines Thomas Kamradt Bernd Sebastian Kamps Revised: 9 April
Approved Vaccines As of 23 May 2021, four COVID-19 vaccines have been approved or authorized for emergency use in the EU or the US (see also Table 1): •
The BioNTech/Pfizer vaccine. Trade name: Comirnaty™ (tozinameran, formerly known as BNT162b2)
•
The Moderna vaccine, also known as mRNA-1273
•
The AstraZeneca/University of Oxford vaccine. Trade name: Vaxzevria™/Covishield™ (formerly known as ChAdOx1 nCoV-19, AZD1222)
•
The Johnson & Johnson (Janssen) vaccine, also known as Ad26.COV2.S
Outside the EU and the US, four other vaccines have been approved: •
BBIBP-CorV, Sinopharm and the Beijing Institute of Biological Products – first approved in China on 30 December 2020
•
Covaxin, Bharat Biotech – first approved in India on 3 January 2021
•
Sputnik-V, Gamaleya Research Institute – first approved in Russia, 28 December 2020
•
Convidecia, CanSinoBIO – first approved in China, 25 February 2021
COVID Reference ENG 006.9
